(VIANEWS) - Northeast Community Bancorp (NECB), Ichor Holdings (ICHR), Genmab (GMAB) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Northeast Community Bancorp (NECB)
37% sales growth and 5.98% return on equity
Northeast Community Bancorp, Inc. is the holding company of Northeast Community Bank, which provides various financial services for consumers and businesses.
Northeast Community Bancorp's sales growth this year is anticipated to be 24.8% and 15.6% for next year.
Year-on-year quarterly revenue growth grew by 11.1%, now sitting on 43.25M for the twelve trailing months.
Volume
Today's last reported volume for Northeast Community Bancorp is 14651 which is 55.02% below its average volume of 32573.
Northeast Community Bancorp's sales growth for the next quarter is 37%. The company's growth estimates for the current quarter and the next is a negative 0% and 540%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.98%.
Volatility
Northeast Community Bancorp's last day, last week, and last month's current intraday variation average was 1.01%, 0.63%, and 1.16%, respectively.
Northeast Community Bancorp's highest amplitude of average volatility was 1.86% (day), 1.38% (last week), and 2.32% (last month), respectively.
Northeast Community Bancorp's Stock Yearly Top and Bottom Value
Northeast Community Bancorp's stock is valued at $11.98 at 01:22 EST, below its 52-week high of $13.06 and way above its 52-week low of $10.02.
Northeast Community Bancorp's Moving Average
Northeast Community Bancorp's worth is above its 50-day moving average of $11.37 and higher than its 200-day moving average of $11.38.2. Ichor Holdings (ICHR)
26.2% sales growth and 13.64% return on equity
Ichor Holdings, Ltd.
Ichor Holdings's sales growth this year is anticipated to be 17.9% and 8.8% for next year.
Year-on-year quarterly revenue growth grew by 10.8%, now sitting on 1.13B for the twelve trailing months.
Volume
Today's last reported volume for Ichor Holdings is 197990 which is 18.31% below its average volume of 242383.
Ichor Holdings's sales growth is a negative 0% for the present quarter and 26.2% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 10% and 19.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.64%.
Volatility
Ichor Holdings's last day, last week, and last month's current intraday variation average was 1.85%, 2.41%, and 3.33%, respectively.
Ichor Holdings's highest amplitude of average volatility was 3.55% (day), 4.86% (last week), and 5.63% (last month), respectively.
Ichor Holdings's Stock Yearly Top and Bottom Value
Ichor Holdings's stock is valued at $27.17 at 01:22 EST, way under its 52-week high of $53.20 and way above its 52-week low of $21.08.
Ichor Holdings's Moving Average
Ichor Holdings's worth is below its 50-day moving average of $27.66 and way under its 200-day moving average of $36.89.3. Genmab (GMAB)
24.4% sales growth and 14.56% return on equity
Genmab A/S is a Danish biotechnology company that develops anti-cancer therapies primarily for patients in Denmark.
Genmab's sales growth this year is expected to be 203.9% and 36.6% for next year.
Year-on-year quarterly revenue growth grew by 28.1%, now sitting on 8.48B for the twelve trailing months.
Volume
Today's last reported volume for Genmab is 932673 which is 38.52% above its average volume of 673296.
Genmab's sales growth for the next quarter is 24.4%. The company's growth estimates for the current quarter and the next is 1028.6% and 570.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.56%.
Volatility
Genmab's last day, last week, and last month's current intraday variation average was 1.96%, 1.27%, and 1.54%, respectively.
Genmab's highest amplitude of average volatility was 3.24% (day), 2.28% (last week), and 2.64% (last month), respectively.
Genmab's Stock Yearly Top and Bottom Value
Genmab's stock is valued at $36.57 at 01:22 EST, way below its 52-week high of $49.07 and way higher than its 52-week low of $26.19.
Genmab's Moving Average
Genmab's value is way above its 50-day moving average of $31.28 and higher than its 200-day moving average of $35.96.4. Iron Mountain Incorporated (IRM)
16.6% sales growth and 48.32% return on equity
Iron Mountain Incorporated, NYSE: IRM) was founded in 1951 and is the world's leader in storage and information management.
Iron Mountain Incorporated's sales growth this year is anticipated to be 16% and 5.8% for next year.
Year-on-year quarterly revenue growth grew by 15.3%, now sitting on 4.66B for the twelve trailing months.
Volume
Today's last reported volume for Iron Mountain Incorporated is 1321480 which is 22.41% below its average volume of 1703210.
Iron Mountain Incorporated's sales growth for the next quarter is 16.6%. The company's growth estimates for the current quarter and the next is 5.3% and 7.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 48.32%.
Volatility
Iron Mountain Incorporated's last day, last week, and last month's current intraday variation average was 0.23%, 1.17%, and 1.39%, respectively.
Iron Mountain Incorporated's highest amplitude of average volatility was 1.74% (day), 2.30% (last week), and 2.48% (last month), respectively.
Iron Mountain Incorporated's Stock Yearly Top and Bottom Value
Iron Mountain Incorporated's stock is valued at $47.37 at 01:22 EST, way below its 52-week high of $58.61 and way above its 52-week low of $41.67.
Iron Mountain Incorporated's Moving Average
Iron Mountain Incorporated's value is under its 50-day moving average of $49.69 and under its 200-day moving average of $49.09.5. BankFinancial Corporation (BFIN)
14% sales growth and 4.49% return on equity
BankFinancial Corporation is the bank holding organization for BankFinancial National Association, which provides various personal, commercial and family banking products.
BankFinancial Corporation's sales growth this year is expected to be 9.9% and 12.2% for next year.
Year-on-year quarterly revenue growth declined by 1.3%, now sitting on 50.7M for the twelve trailing months.
Volume
Today's last reported volume for BankFinancial Corporation is 3167 which is 83.91% below its average volume of 19686.
BankFinancial Corporation's sales growth is a negative 0% for the present quarter and 14% for the next. The company's growth estimates for the current quarter and the next is 23.1% and 66.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.49%.
Volatility
BankFinancial Corporation's last day, last week, and last month's current intraday variation average was 0.87%, 0.43%, and 0.29%, respectively.
BankFinancial Corporation's highest amplitude of average volatility was 1.42% (day), 1.06% (last week), and 1.27% (last month), respectively.
BankFinancial Corporation's Stock Yearly Top and Bottom Value
BankFinancial Corporation's stock is valued at $9.28 at 01:23 EST, way under its 52-week high of $12.79 and higher than its 52-week low of $9.18.
BankFinancial Corporation's Moving Average
BankFinancial Corporation's value is below its 50-day moving average of $9.52 and way under its 200-day moving average of $10.50.6. Pinnacle Financial Partners (PNFP)
13.8% sales growth and 10.37% return on equity
Pinnacle Financial Partners, Inc., along with its affiliates, is the bank holding company of Pinnacle Bank, which provides different banking products and services throughout the United States.
Pinnacle Financial Partners's sales growth this year is expected to be 24.9% and 13.5% for next year.
Year-on-year quarterly revenue growth grew by 10.3%, now sitting on 1.34B for the twelve trailing months.
Volume
Today's last reported volume for Pinnacle Financial Partners is 302898 which is 35.02% below its average volume of 466145.
Pinnacle Financial Partners's sales growth for the next quarter is 13.8%. The company's growth estimates for the current quarter and the next is a negative 1.2% and 4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.37%.
Volatility
Pinnacle Financial Partners's last day, last week, and last month's current intraday variation average was 1.71%, 1.61%, and 1.68%, respectively.
Pinnacle Financial Partners's highest amplitude of average volatility was 1.87% (day), 2.32% (last week), and 2.86% (last month), respectively.
Pinnacle Financial Partners's Stock Yearly Top and Bottom Value
Pinnacle Financial Partners's stock is valued at $70.64 at 01:23 EST, way under its 52-week high of $111.31 and higher than its 52-week low of $67.90.
Pinnacle Financial Partners's Moving Average
Pinnacle Financial Partners's value is below its 50-day moving average of $75.61 and way below its 200-day moving average of $91.19.7. Graco (GGG)
7.3% sales growth and 28.32% return on equity
Graco Inc. develops, produces, markets, and sells systems and equipment that move, measure and control fluids and powders worldwide.
Graco's sales growth this year is expected to be 6.2% and 4.6% for next year.
Year-on-year quarterly revenue growth grew by 8.8%, now sitting on 2.03B for the twelve trailing months.
Volume
Today's last reported volume for Graco is 318511 which is 52.27% below its average volume of 667359.
Graco's sales growth for the next quarter is 7.3%. The company's growth estimates for the current quarter and the next is 8.1% and 17.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.32%.
Volatility
Graco's last day, last week, and last month's current intraday variation average was 0.32%, 1.39%, and 1.20%, respectively.
Graco's highest amplitude of average volatility was 1.71% (day), 2.17% (last week), and 2.18% (last month), respectively.
Graco's Stock Yearly Top and Bottom Value
Graco's stock is valued at $61.80 at 01:23 EST, way under its 52-week high of $81.09 and higher than its 52-week low of $56.48.
Graco's Moving Average
Graco's value is higher than its 50-day moving average of $60.47 and way below its 200-day moving average of $69.56.8. FMC Corporation (FMC)
6.9% sales growth and 27.4% return on equity
FMC Corporation is an agricultural science company that provides professional pest and grass management products, crop protection and plant health.
FMC Corporation's sales growth this year is expected to be 7.7% and 5.7% for next year.
Year-on-year quarterly revenue growth grew by 13%, now sitting on 5.2B for the twelve trailing months.
Volume
Today's last reported volume for FMC Corporation is 602545 which is 37.79% below its average volume of 968635.
FMC Corporation's sales growth for the next quarter is 6.9%. The company's growth estimates for the ongoing quarter and the next is 3.9% and 11.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 27.4%.
Volatility
FMC Corporation's last day, last week, and last month's current intraday variation average was 0.11%, 1.19%, and 1.36%, respectively.
FMC Corporation's highest amplitude of average volatility was 1.53% (day), 2.27% (last week), and 2.73% (last month), respectively.
FMC Corporation's Stock Yearly Top and Bottom Value
FMC Corporation's stock is valued at $105.90 at 01:23 EST, way under its 52-week high of $140.99 and way higher than its 52-week low of $87.27.